Altered cardiac hormone and contractile protein messenger RNA levels following left ventricular myocardial infarction in the rat: An in situ hybridization histochemical study

Cardiovascular Research

Volumn 37, Issue 1, 1998, Pages 187-201

  Young, Richard L ^a   Gundlach, Andrew L ^a   Louis, William J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Actin; Atrial natriuretic peptide; Cardiac hypertrophy; In situ hybridization histochemistry; Myocardial infarction; Myosin; Wistar rat

Indexed keywords

ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; CONTRACTILE PROTEIN; HORMONE PRECURSOR; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; OLIGONUCLEOTIDE; SULFUR 35;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WEIGHT; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG WEIGHT; NONHUMAN; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; RAT;

ACTINS; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; FEMALE; IN SITU HYBRIDIZATION; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0031936149     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00205-8     Document Type: Article

References (59)

1. 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes. J Clin Invest. 80:1987;1194-1199.
2. Schwartz K., de la Bastie D., Bouveret P., Oliviére P., Alonso S., Buckingham M. α-Skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circ Res. 59:1986;551-555.
3. Schiaffino S., Samuel J.L., Sassoon D.et al. Nonsynchronous accumulation of α-skeletal actin and β-myosin heavy chain mRNAs during early stages of pressure-overload-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res. 64:1989;937-948.
4. Chassagne C., Wisnewsky C., Schwartz K. Antithetical accumulation of myosin heavy chain but not α-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy. Circ Res. 72:1993;857-864.
5. Feldman A.M., Weinberg E.O., Ray P.E., Lorell B.H. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 73:1993;184-192.
6. Mercadier J.J., Lompré A.M., Wisnewsky C.et al. Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ Res. 49:1981;525-532.
7. Anversa P., Li P., Malhotra A., Zhang X., Herman M.V., Capasso J.M. Effects of hypertension and coronary constriction on cardiac function, morphology and contractile proteins in rats. Am J Physiol. 265:1993;H713-H724.
8. Meggs L.G., Tillotson J., Huang H., Sonnenblick E.H., Capasso J.M., Anversa P. Noncoordinate regulation of alpha-1 adrenoreceptor coupling and reexpression of alpha skeletal actin in myocardial infarction-induced left ventricular failure in rats. J Clin Invest. 86:1990;1451-1458.
9. Nadal-Ginard B., Mahdavi V. Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoform switches. J Clin Invest. 84:1989;1693-1700.
10. Hewett T.E., Grupp I.L., Grupp G., Robbins J. α-Skeletal actin is associated with increased contractility in the mouse heart. Circ Res. 74:1994;740-746.
11. 1-Adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells: effects on myosin light chain-2 gene expression. J Biol Chem. 263:1988;7352-7358.
12. 1-adrenergic stimulation of neonatal rat ventricular cells. J Biol Chem. 266:1991;7759-7768.
13. Drexler H., Hänze J., Finckh M., Lu W., Just H., Lang R.E. Atrial natriuretic peptide in a rat model of cardiac failure: Atrial and ventricular mRNA, atrial content, plasma levels and effect of volume loading. Circulation. 79:1989;620-633.
14. Trybus K.M. Role of myosin light chains. J Muscle Res Cell Motil. 15:1994;587-594.
15. Morano I., Hofman F., Zimmer M., Ruegg J.C. The influence of P-light chain phosphorylation by myosin light chain kinase on the calcium sensitivity of chemically skinned heart fibers. FEBS Lett. 189:1985;221-224.
16. Chien K.R., Knowlton K.U., Zhu H., Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 5:1991;3037-3046.
17. Young R.L., Gundlach A.L., Louis W.J. Temporal expression of cardiac contractile and regulatory genes following left ventricular myocardial infarction in the rat heart. J Hypertens. 12:1994;S110.
18. Pfeffer M.A., Pfeffer J.M., Fishbein M.C.et al. Myocardial infarct size and ventricular function in rats. Circ Res. 44:1979;503-512.
19. Rowley K.G., Tung L.H., Hodsman G.P.et al. Altered alpha 1-adrenoceptor-mediated responses in atria of rats with chronic left ventricular infarction. J Cardiovasc Pharmacol. 17:1991;474-479.
20. Maki M., Takayanagi R., Misono K.S., Pandey K.N., Tibbetts C., Inagami T. Structure of rat atrial natriuretic factor precursor deduced from cDNA structure. Nature. 309:1984;722-724.
21. Mayer Y., Czosnek H., Zeelon P.E., Yaffe D., Nudel U. Expression of the genes coding for the skeletal muscle and cardiac actins in the heart. Nucleic Acids Res. 12:1984;1087-1100.
22. Shani M., Nudel U., Zevin-Sonkin D., Zakut R.et al. Skeletal muscle actin mRNA. Characterization of the 3′ untranslated region. Nucleic Acids Res. 9:1981;579-589.
23. Kumar C.C., Cribbs L., Delaney P., Chien K.R., Siddiqui M.A.Q. Heart myosin light chain 2 gene: Nucleotide sequence of full length cDNA and expression in normal and hypertensive rat. J Biol Chem. 261:1986;2866-2872.
24. Kraft R., Brave-Zehnder M., Taylor D., Leinwand L.A. Complete nucleotide sequence of full length cDNA for rat beta myosin heavy chain. Nucleic Acid Res. 17:1989;7529-7530.
25. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol. 215:1990;403-410.
26. O'Shea RD, Gundlach AL. Quantitative analysis of in situ hybridization histochemistry. In: Wisden W, Morris BJ, editors. In situ hybridization protocols for the brain. London: Academic Press, 1994:57-78.
27. Dagerlind Å., Friberg K., Bean A.J., Hökfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry. 98:1992;39-49.
28. Wisden W, Morris BJ. In situ hybridization with synthetic oligonucleotide probes. In: Wisden W, Morris BJ, editors. In situ hybridization protocols for the brain. London: Academic Press, 1994:9-34.
29. Pasternak RC, Braunwald E, Sobel BE. Acute myocardial infarction. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine (4th ed.). Philadelphia: WB Saunders, 1992:1200-1291.
30. Li P., Park C., Micheletti R.et al. Myocyte performance during evolution of myocardial infarction in rats: effects of propionyl-L-carnitine. Am J Physiol. 268:1995;H1702-H1713.
31. Ito B.R. Gradual onset of myocardial ischaemia results in reduced myocardial infarction. Association with reduced contractile function and metabolic downregulation. Circulation. 91:1995;2058-2070.
32. Granger H.J., Ziche M., Hawker J.R. Jr., Meininger C.J., Czisny L.E., Zawieja D.C. Molecular and cellular basis of myocardial angiogenesis. Cell Mol Biol Res. 40:1994;81-85.
33. Kajstura J., Cheng W., Reiss K.et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
34. Olivetti G., Capasso J.M., Sonnenblick E.H., Anversa P. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res. 67:1990;23-34.
35. Ruskoaho H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol Rev. 44:1992;479-602.
36. Larsen T.H., Sætersdal T. Regional appearance of atrial natriuretic peptide in the ventricles of infarcted rat hearts. Virchows Archiv B Cell Pathol. 64:1993;309-314.
37. Komuro I., Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol. 55:1993;55-75.
38. Capasso J.M., Li P., Zhang X., Anversa P. Heterogeneity of ventricular remodelling after acute myocardial infarction in rats. Am J Physiol. 262:1992;H486-H495.
39. Adachi S., Ito H., Ohta Y.et al. Distribution of mRNAs for natriuretic peptides in RV hypertrophy after pulmonary artery banding. Am J Physiol. 268:1995;H162-H169.
40. Itoh H., Pratt R.E., Ohno M., Dzau V.J. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension. 19:1992;758-761.
41. Cao L., Gardiner G. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension. 25:1995;227-234.
42. Carrier L., Boehler K.R., Chassagne C., de la Bastie-Wisnewsky C., Lakatta E.G., Schwartz K. Expression of the sarcomeric actin isogenes in the rat heart with development and senescence. Circ Res. 70:1992;999-1005.
43. 1 receptor subtype. Circ Res. 73:1993;413-423.
44. Ito H., Hirata Y., Hiroe M.et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 69:1991;209-215.
45. Schwartz K, Carrier L, Mercadier JJ, Lompré AM, Boheler KR. Molecular phenotype of the hypertrophied and failing myocardium. Circulation 1993;87:VII-5-VII-10.
46. Boheler K.R., Carrier L., de la Bastie D.et al. Skeletal actin mRNA increases in human heart during ontogenic development and is the major isoform of control and failing adult hearts. J Clin Invest. 88:1991;323-330.
47. Chien K.R., Zhu H., Knowlton K.U.et al. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol. 55:1993;77-95.
48. Lee K.J., Rockman H., Ross J. Jr., Chien K.R. Ventricular specific and inducible expression of MLC-2 luciferase fusion genes during in vivo hypertrophy in transgenic mice. Circulation. 86:1992;I94.
49. Kwiatkowska-Patzer B., Prior G., Zak R. Increased synthesis of the phosphorylated form of the myosin light chains in cardiac hypertrophy in the rat. Adv Myocardiol. 4:1983;183-188.
50. Cummins P. Transitions in human atrial and ventricular myosin light-chain isoenzymes in response to cardiac-pressure-overload-induced hypertrophy. Biochem J. 205:1982;195-204.
51. Henkel R.D., Kammerer C.M., Escobedo L.V., VandeBerg J.L., Walsh R.A. Correlated expression of atrial myosin heavy chain and regulatory light chain isoforms with pressure overload hypertrophy in the non-human primate. Cardiovasc Res. 27:1993;416-422.
52. McDonough P.M., Glembotski C.C. Induction of atrial natriuretic factor and myosin light chain-2 gene expression in cultured ventricular myocytes by electrical stimulation of contraction. J Biol Chem. 267:1992;11655-11668.
53. Bugaisky L.B., Anderson P.G., Hall R.S., Bishop S.P. Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat. Circ Res. 66:1990;1127-1132.
54. Chen J.J., Wang D.L., Shih N.L., Hsu K.H., Lien W.P., Liew C.C. Regulation of human cardiac myosin heavy chain genes: the effect of catecholamine. Biochem Biophys Res Commun. 188:1992;547-553.
55. Wang D.L., Chen J.J., Shih N.L.et al. Endothelin stimulates cardiac alpha- and beta-myosin heavy chain gene expression. Biochem Biophys Res Commun. 183:1992;1260-1265.
56. Yamazaki T., Shiojima I., Komuro I., Nagai R., Yazaki Y. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction. J Hypertens. 12:1994;S23-S27.
57. Mercadier J.J., de la Bastie D., Ménasché P.et al. Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: A quantitative study. J Am Coll Cardiol. 9:1987;1024-1030.
58. Gorza L., Mercadier J.J., Schwartz K., Thornell L.E., Sartore S., Schiaffino S. Myosin types in the human heart. An immunofluorescence study of normal and hypertrophied atrial and ventricular myocardium. Circ Res. 54:1984;694-702.
59. Shah A.M. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res. 31:1996;847-867.